Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AUPH
AUPH logo

AUPH News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AUPH News

Aurinia Reports 23% Revenue Growth in Q1

3d agostocktwits

Aurinia Pharmaceuticals Reports Q1 Earnings Growth

4d agoNASDAQ.COM

Aurinia Pharmaceuticals Q1 Earnings Exceed Expectations

4d agoseekingalpha

Biotech Landscape Update: Regulatory Approvals and Acquisitions

Apr 03 2026NASDAQ.COM

Aurinia Acquires Kezar Life Sciences for $6.955 per Share

Mar 30 2026seekingalpha

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences in $6.955 Per Share Deal

Mar 30 2026NASDAQ.COM

AURINIA PHARMACEUTICALS TO PURCHASE KEZAR LIFE SCIENCES FOR $6.955 PER SHARE IN CASH, ALONG WITH A CONTINGENT VALUE RIGHT

Mar 30 2026moomoo

Aurinia Appoints New CEO and CFO Amid Shareholder Concerns

Mar 23 2026stocktwits

AUPH Events

05/07 08:10
Aurinia Reports Q1 Revenue of $77.7M, Exceeds Consensus
Reports Q1 revenue $77.7M, consensus $76.98M. "Aurinia remains steadfast in its mission to become a leading company that benefits patients suffering from autoimmune diseases," stated Kevin Tang, Chief Executive Officer. "LUPKYNIS is emerging as a standard-of-care treatment for lupus nephritis, and aritinercept, now in clinical development for three potential indications, has therapeutic potential across a wide range of autoimmune disorders."
05/07 08:10
Aurinia CEO Emphasizes LUPKYNIS as Standard Treatment for Lupus Nephritis
"Aurinia remains steadfast in its mission to become a leading company that benefits patients suffering from autoimmune diseases," stated Kevin Tang, Chief Executive Officer. "LUPKYNIS is emerging as a standard-of-care treatment for lupus nephritis, and aritinercept, now in clinical development for three potential indications, has therapeutic potential across a wide range of autoimmune disorders."
03/30 16:40
Major Averages Close Mixed as Oil Prices Continue to Rise
The major averages closed mixed, with the S&P 500 and Nasdaq ending lower despite earlier gains, as oil prices keep rising amid continued conflict in the Middle East. Of note, President Trump said the U.S. is in "serious discussions" with Iran to end its military operations. However, he added that if a peace deal is not reached "shortly" and the Strait of Hormuz is not reopened, the U.S. will "conclude our lovely 'stay' in Iran by blowing up and completely obliterating all of their Electric Generating Plants, Oil Wells and Kharg Island (and possibly all desalinization plants!), which we have purposefully not yet 'touched.'" The comments came after the president stated that Tehran had accepted most of the U.S.'s 15-point plan to end the war.Additionally, Federal Reserve chair Jerome Powell said during a discussion at Harvard University that even with rising energy prices, he views inflation expectations as "well anchored beyond the short term." Powell added that he is "optimistic" about the medium- and long-run outlook for the U.S. economy and that the Fed is watching private credit "super carefully."Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:SyscoJetro Restaurant Depot for a total enterprise value of $29.1BUberglobal chauffeur service leader BlacklaneAuriniaKezar Life Sciencesfor $6.955 per share in cash plus a non-transferable contingent value rightTJX'sboard raised itsand said it plans $2.5B-$2.75B of share repurchases for FY27Apollois near a deal to acquire Atlantic Aviation from KKR,2. WALL STREET CALLS:CrowdStriketo Outperform from Peer Perform at Wolfe ResearchExpediato Buy from Hold at JefferiesInstacartto Buy from Hold at JefferiesDole, Nomad Foodsto Hold at Deutsche BankStarbuckswith an Underperform at BNP Paribas3. AROUND THE WEB:JetBluetold CNBC it is increasing bag fees amid soaring fuel pricesGeneral Motorsis moving to a six days per week production schedule at its Flint plant, Reuters saysBanks led by JPMorganare dealing with pushback related to the terms of a $7.2B debt deal to fund Clayton, Dubilier & Rice's takeover of Sealed Air, Bloomberg reportsYouTubeemployees have admitted their goal was "viewer addiction" and shut down proposed safety tools for kids since they did not provide a sufficient return on investment, NY Post saysAn analysis of billions of anonymized credit card transactions by consumer transaction analysis company Indagari indicates that Claude is seeing record growth in paid subscribers, with subscriptions more than doubling this year according to Anthropic, TechCrunch says4. MOVERS:Compass Diversifiedadvanced after announcing it willto Archer for $292.5MiQiyigained in New York afteron HKEXViridiandeclined after announcing results from itsFermiclosed lower afterBoston Scientificfell after Raymond Jamesits rating on the stock5. EARNINGS/GUIDANCE:Alaska AirprovidedUSA Rare Earth, with CEO Barbara Humpton commenting, "2025 was the year that USA Rare Earth set the foundation to execute our integrated rare earth growth strategy"Spirecut itsNeumora Therapeutics, with EPS missing consensusCBAK Energy Technology, with revenue higher year-over-yearINDEXES:The Dow rose 49.50, or 0.11%, to 45,216.14, the Nasdaq lost 153.72, or 0.73%, to 20,794.64, and the S&P 500 declined 25.13, or 0.39%, to 6,343.72.
03/30 16:00
Aurinia Pharmaceuticals Acquires Kezar Life Sciences for $6.955 per Share
After Aurinia Pharmaceuticals (AUPH) announced an agreement to acquire Kezar Life Sciences (KZR) for $6.955 in cash per share plus one non-transferable contingent value right, Jefferies said the deal valuation "makes sense" given the stage of development and trials needed to bring zetomipzomib to market. The firm maintains a Hold rating and $7 price target on Kezar shares.

AUPH Monitor News

No data

No data

AUPH Earnings Analysis

No Data

No Data

People Also Watch